Literature DB >> 10084480

Elevated O2 cost of ventilation contributes to tissue wasting in COPD.

E T Mannix1, F Manfredi, M O Farber.   

Abstract

BACKGROUND AND OBJECTIVES: Thirty to 50% of all COPD patients experience tissue wasting that may be caused by hypermetabolism, but the cause of the perturbed metabolic state is unclear. We hypothesized that the elevated O2 cost of ventilation (O2 COV) may be a contributing factor. All of the data are presented as means (+/-SEM). Ten hypoxemic (a PaO2 of 54+/-3 mm Hg) stable COPD patients (an FEV1/FVC ratio of 42+/-4%) and five healthy control subjects were studied. The patients were divided into two groups based on nutritional status. Group 1 (n = 6) was malnourished (a body mass index [BMI] of 17.6+/-0.7 kg/m2), and group 2 (n = 4) was normally nourished (a BMI of 26.0+/-3 kg/m2). The O2 COV was determined by measuring the change in the oxygen consumption (VO2) and the minute ventilation (VE) caused by CO2-induced hyperventilation. RESULTS AND
CONCLUSIONS: Group 1 had an elevated O2 COV when compared to group 2 and the control group, respectively: 16.4+/-1.0 vs 9.7+/-1.0 and 2.4+/-0.2 mL O2/L of VE (p < 0.05). The VO2 at rest was higher for group 1 than for group 2 and the control group, respectively: 4.5+/-0.3 vs 3.1+/-0.5 and 3.4+/-0.2 mL/kg/min (p < 0.05). The resting energy expenditure (REE) % predicted for group 1 was also higher than group 2 and the control group, respectively: 125+/-3% vs 87+/-7% and 97+/-2% (p < 0.05). Significant correlations were observed that implicate the increased O2 COV as a cause of tissue wasting: O2 COV vs BMI (r = -0.79; p = 0.007), O2 COV vs REE % predicted (r = 0.66; p = 0.039), and REE % predicted vs BMI (r = -0.83; p = 0.003). The O2 COV was also correlated with lung function: FEV1/FVC vs O2 COV (r = -0.84; p = 0.002). We conclude that in these COPD patients the O2 COV is associated with an increased metabolic rate which, in turn adversely affects the nutritional status.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084480     DOI: 10.1378/chest.115.3.708

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Energy expenditure in obstructive sleep apnea: validation of a multiple physiological sensor for determination of sleep and wake.

Authors:  Denise M O'Driscoll; Anthony R Turton; Janet M Copland; Boyd J Strauss; Garun S Hamilton
Journal:  Sleep Breath       Date:  2012-02-10       Impact factor: 2.816

Review 2.  Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options?

Authors:  Jean K Berry; Charles Baum
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study.

Authors:  Ernesto Crisafulli; Claudio Beneventi; Veronica Bortolotti; Nicoletta Kidonias; Leonardo M Fabbri; Alfredo Chetta; Enrico M Clini
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

4.  Saturated Fat Intake Is Associated with Lung Function in Individuals with Airflow Obstruction: Results from NHANES 2007⁻2012.

Authors:  Kasey Cornell; Morshed Alam; Elizabeth Lyden; Lisa Wood; Tricia D LeVan; Tara M Nordgren; Kristina Bailey; Corrine Hanson
Journal:  Nutrients       Date:  2019-02-01       Impact factor: 5.717

Review 5.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.